Lisa Wright - 01 Jun 2021 Form 4 Insider Report for Vericel Corp (VCEL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Jun 2021, 16:15:36 UTC
Next SEC filing
29 Apr 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sean Flynn, Attorney-in-Fact for Lisa Wright

Key filing fact

Lisa Wright filed Form 4 for Vericel Corp (VCEL) on 03 Jun 2021.

Key facts

  • This page summarizes Lisa Wright's Form 4 filing for Vericel Corp (VCEL).
  • 4 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 03 Jun 2021, 16:15.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VCEL transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+1,300
Change %
Price
$0.000000
Shares after
1,300
Date
01 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,300
Exercise price
Footnotes
F1, F2, F3
VCEL transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+3,250
Change %
Price
$0.000000
Shares after
3,250
Date
01 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,250
Exercise price
$56.49
Footnotes
F4
VCEL transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+5,877
Change %
Price
$0.000000
Shares after
5,877
Date
01 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,877
Exercise price
$56.49
Footnotes
F5
VCEL transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+2,351
Change %
Price
$0.000000
Shares after
2,351
Date
01 Jun 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,351
Exercise price
Footnotes
F1, F3, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.

Footnote F2

These RSUs vest in equal annual installments over three years, beginning on June 1, 2021.

Footnote F3

No expiration date for this type of award.

Footnote F4

These options, representing the right to purchase a total of 3,250 shares, shall vest and become exercisable in equal monthly installments over three years, beginning on June 1, 2021, contingent upon continued service to the Company.

Footnote F5

These options, representing the right to purchase a total of 5,877 shares, shall vest and become exercisable in equal monthly installments beginning on June 1, 2021, and shall become fully vested and exercisable on the earlier of the date of the Company's next annual meeting of shareholders or April 27, 2022, contingent upon continued service to the Company.

Footnote F6

These RSUs shall vest on the earlier of June 1, 2022 or the date of the Company's next annual meeting of shareholders, contingent upon continued service to the Company.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .